Braeden Lichti → Bluejay Diagnostics, Inc. BJDX

Stake: — Shares: 0 CUSIP: 095633608 Class: Common Stock, par value $0.0001 per share

Item 4 — Purpose of Transaction

Since the filing of the Reporting Persons' Schedule 13D with the SEC on March 11, 2026, the Reporting Persons have disposed of all shares of common stock of the Issuer. As of June 2, 2026, the Reporting Persons no longer beneficially own any shares of the Issuer's Common Stock.

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

3 13D/G filings on this issuer

2 other filings besides this one

Filer Track Record

2 filings by this filer

1 other filing in the data moat

Short Interest · settle 2026-07-15

DTC 1.00

569,675 shares short · +25.1% vs prior

Post-Filing Returns · since 2026-06-02 on BJDX

+1 day

+3.9%

+5 days

+20.5%

+30 days

-73.7%

+60 days

—

+90 days

—

+180 days

—

Anchor price 4.34 on closest trading day on/after 2026-06-02. Source: Yahoo Finance daily adj_close (split + dividend adjusted).

Other 13D/G Filings on Bluejay Diagnostics, Inc.

Filed	Form	Filer	Stake	Shares
2026-06-05	SCHEDULE 13G	INTRACOASTAL CAPITAL, LLC	—	—	view →
2026-06-02	SCHEDULE 13D/A	NORTHSTRIVE FUND II LP	—	0	view →

Other Filings by Braeden Lichti

Filed	Form	Issuer	Stake	Shares
2026-06-03	SCHEDULE 13D/A	PMGC Holdings Inc. ELAB	7.40%	450,313	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →